Share on StockTwits

Stock analysts at Piper Jaffray boosted their target price on shares of CareFusion (NYSE:CFN) from $45.00 to $48.00 in a report issued on Friday. Piper Jaffray’s price objective suggests a potential upside of 12.97% from the stock’s previous close.

A number of other firms have also recently commented on CFN. Analysts at JPMorgan Chase & Co. raised their price target on shares of CareFusion from $44.00 to $48.00 in a research note on Friday. Separately, analysts at BMO Capital Markets raised their price target on shares of CareFusion from $46.00 to $48.00 in a research note on Friday. Finally, analysts at Stifel Nicolaus raised their price target on shares of CareFusion from $42.00 to $49.00 in a research note on Friday. They now have a “buy” rating on the stock. Five research analysts have rated the stock with a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $45.17.

CareFusion (NYSE:CFN) opened at 42.49 on Friday. CareFusion has a one year low of $35.01 and a one year high of $45.81. The stock’s 50-day moving average is $44.32 and its 200-day moving average is $41.65. The company has a market cap of $8.809 billion and a price-to-earnings ratio of 23.55.

CareFusion (NYSE:CFN) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.79 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.72 by $0.07. The company had revenue of $1.12 billion for the quarter, compared to the consensus estimate of $1.04 billion. During the same quarter in the previous year, the company posted $0.55 earnings per share. The company’s revenue for the quarter was up 24.3% on a year-over-year basis. Analysts expect that CareFusion will post $2.68 EPS for the current fiscal year.

CareFusion Corporation (NYSE:CFN) is a global medical technology company.

Receive News & Ratings for CareFusion Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareFusion Co and related companies with Analyst Ratings Network's FREE daily email newsletter.